Delivery Order SPE2DB20D1109-SPE2DB24FP44G
Award Date
7/3/24
Potential Completion Date
7/5/24
Potential Value
$4.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,031,544 units of the prescription drug Vyvanse 70 mg capsules. The $12,366.19 firm-fixed-price delivery order was awarded on June 28, 2024 by the Defense Logistics Agency, a component of the Department of Defense. The contract has a completion date of July 1, 2024 and does not include a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, has a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,978,188 units of Vyvanse 40 mg capsules. The $1,567.08 contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, and has a completion date of June 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of 4,566,179,118 units of the prescription drug Vyvanse 30 mg capsules. The $1,150.57 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency, and has an ultimate completion date of October 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,895 units of the drug Vyvanse 60 mg capsules. The fixed-price delivery order, valued at $1,378.00, has a completion date of January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,752,978 units of the pharmaceutical product Vyvanse 50 mg capsules. The $2,025.50 fixed-price contract was awarded on May 30, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 31, 2024. The contract does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,930,073 units of the prescription medication Vyvanse 40 mg capsules. The contract has a ceiling value of $1,313.24 and a completion date of June 18, 2024. It was awarded by the Defense Logistics Agency (DLA) on June 17, 2024 as a firm fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,804,595 units of the pharmaceutical product Vyvanse 60 mg capsules. The contract has a total ceiling value of $2,626.28 and is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract has no set-aside designation and has an ultimate completion date of June 5, 2024. Amerisourcebergen, a major...
This federal contract award is for the delivery of 4,565,005,875 units of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $1,293.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division on June 26, 2024, with an ultimate completion date of June 27, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
The federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the leading pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Vyvanse 10 mg capsules to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. This firm fixed price delivery order, valued at $3,534.06, has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, is for the supply of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA). The $3,017.00 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...